Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06193954 · ClinicalTrials.gov registry record · NA

VasoStar Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions

A NA study of Chronic Total Occlusion of Coronary Artery and Chronic Angina, sponsored by VasoStar.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
2
Study locations

NCT06193954 is a NA study of Chronic Total Occlusion of Coronary Artery and Chronic Angina that is actively recruiting participants, run by VasoStar. The registered enrollment target is 10 participants, below the 173-participant average among 3 other Chronic Total Occlusion of Coronary Artery trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06193954, a NA study of Chronic Total Occlusion of Coronary Artery and Chronic Angina, is actively recruiting participants, sponsored by VasoStar.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
2
Study locations

Study Summary

The goal of this project is to provide an improvement in wire performance to expedite crossing difficult lesions in the coronary vasculature.

Interventions

  • DEVICE VasoStar guidewire system

Study Locations (2)

Georgia

  • Emory University - Atlanta

Ohio

  • Summa Health - Akron

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-06-10
Est. Completion 2026-12-31
Phase NA

Sponsor

VasoStar

1 total trials

What the Registry Record Tells You About NCT06193954

The ClinicalTrials.gov registry entry for NCT06193954 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 173-participant average among 3 other Chronic Total Occlusion of Coronary Artery trials with a reported enrollment target (94% lower). The listed sponsor is VasoStar, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Total Occlusion of Coronary Artery appearing as the primary indexed condition, and to 1 intervention - of which VasoStar guidewire system is the first listed.

NCT06193954 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Ohio.

Frequently Asked Questions

What is clinical trial NCT06193954 about?

NCT06193954 is a clinical study titled "VasoStar Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions". The goal of this project is to provide an improvement in wire performance to expedite crossing difficult lesions in the coronary vasculature.

What is the current status of trial NCT06193954?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-06-10. Estimated completion is 2026-12-31.

What conditions does trial NCT06193954 study?

This clinical trial studies the following conditions: Chronic Total Occlusion of Coronary Artery, Chronic Angina.

What interventions are being tested in trial NCT06193954?

The interventions under investigation include: VasoStar guidewire system (DEVICE).

Who is sponsoring clinical trial NCT06193954?

This trial is sponsored by VasoStar, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06193954 being conducted?

This trial has 2 study locations across Georgia, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Total Occlusion of Coronary Artery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.